Suvi Hartikainen
YOU?
Author Swipe
View article: Cardiometabolic disorders affect myocardial [18F]fluorodeoxyglucose uptake– impact on diagnostic PET/CT imaging
Cardiometabolic disorders affect myocardial [18F]fluorodeoxyglucose uptake– impact on diagnostic PET/CT imaging Open
Background Corresponding to impaired insulin response in skeletal muscle, insulin resistance may occur in the myocardium, suggesting a link between cardiometabolic disorders and cardiac glucose metabolism. We aimed to investigate whether c…
View article: Heparin does not improve myocardial glucose metabolism suppression in [18 F]FDG PET/CT in patients with low β-hydroxybutyrate level
Heparin does not improve myocardial glucose metabolism suppression in [18 F]FDG PET/CT in patients with low β-hydroxybutyrate level Open
View article: Review of Myocardial Ischemia, Scar, and Viability Estimation with Molecular Magnetic Resonance Imaging
Review of Myocardial Ischemia, Scar, and Viability Estimation with Molecular Magnetic Resonance Imaging Open
Background: Cardiovascular diseases, particularly myocardial ischemia from coronary artery obstruction, remain a leading cause of global morbidity. This review explores cardiac molecular magnetic resonance imaging (mMRI) and other molecula…
View article: Point‐of‐care β‐hydroxybutyrate measurement predicts adequate glucose metabolism suppression in cardiac FDG‐PET/CT
Point‐of‐care β‐hydroxybutyrate measurement predicts adequate glucose metabolism suppression in cardiac FDG‐PET/CT Open
Aims The aims of our study were to evaluate whether point‐of‐care β‐hydroxybutyrate (BHB) measurement can be used to identify patients with adequate cardiac glucose metabolism suppression for cardiac [ 18 F]‐fluoro‐2‐deoxy‐ d ‐glucose‐posi…